LECROSE: Iron Sucrose Injection (100 mg/5 ml) for rapid hemoglobin increase, treating postpartum hemorrhage, surgical anemia, iron deficiency, chronic blood loss, and kidney disease.
LECROSE is an advanced Iron Sucrose Injection designed to address iron deficiency and anemia effectively. It ensures a rapid increase in hemoglobin (HB) levels, making it particularly beneficial for patients with critical iron needs.
Key Highlights:
• 87.5% of pregnant Indian women are anemic, making LECROSE a critical solution for maternal care.
• More than 50% of women of childbearing age suffer from iron deficiency.
• Anemia contributes to 20% of maternal deaths, emphasizing the importance of timely treatment.
• Three out of four children below four years old are anemic.
Why Choose LECROSE?
• Effectively treats anemia caused by postpartum hemorrhage, surgical recovery, and chronic conditions.
• Delivers fast and reliable results in increasing iron and hemoglobin levels.
• Safe and targeted for intravenous administration in clinical settings.